The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity

Bryan A. Ward; Christopher J. Gorski; David R. Jones; Stephen D. Hall; David A. Flockhart; Zeruesenay Desta

doi:10.1124/jpet.103.049601

OtherAbsorption, Distribution, Metabolism, and Excretion

The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity

Bryan A. Ward, Christopher J. Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta

Journal of Pharmacology and Experimental Therapeutics April 3, 2003, DOI: https://doi.org/10.1124/jpet.103.049601

Bryan A. Ward

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christopher J. Gorski

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David R. Jones

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephen D. Hall

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David A. Flockhart

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zeruesenay Desta

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 377, Issue 2

1 May 2021

Table of Contents
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

OtherAbsorption, Distribution, Metabolism, and Excretion

The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity

Bryan A. Ward, Christopher J. Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta

Journal of Pharmacology and Experimental Therapeutics April 3, 2003, DOI: https://doi.org/10.1124/jpet.103.049601

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherAbsorption, Distribution, Metabolism, and Excretion

The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity

Bryan A. Ward, Christopher J. Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta

Journal of Pharmacology and Experimental Therapeutics April 3, 2003, DOI: https://doi.org/10.1124/jpet.103.049601

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity

In this issue

The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity

Citation Manager Formats

The cytochrome P450 2B6 is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDs therapy and utility of efavirenz as substrate marker of CYP2B6 catalytic activity

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals